As I understand it, Grifols' subQ formulation as of now is only approved for use in the US. This early into the Grifols product launch there are only guesstimates regarding projected sales and the rate for sales growth. To be prepared there my be proactive stocking up of infusion pumps by end users both in the US and in Europe?
News 
Market Data 
Discover 
